Zyprexa Maker Announces Litigation Settlement

Eli Lilly, the maker of the anti-psychotic pharmaceutical Zyprexa today issued a press release today announcing a large-scale settlement with 14 plaintiffs' law firms (or groups of plaintiffs' law firms) that are involved in Zyprexa product liability litigation.

It is estimated that at least 18,000 cases -- the vast majority of existing Zyprexa product liability litigation cases -- are covered by this settlement. Approximately 1,200 claims that have been identified to Eli Lilly are not included in this settlement.

For more information:

• Lilly and Plaintiffs' Attorneys Enter Into Agreements to Settle Zyprexa® Product Liability Litigation (Eli Lilly press release, January 4, 2007)
• Zyprexa.com (product information)
• ZyprexaFacts.com (from Eli Lilly)
• Zyprexa section from FindLaw for the Public